comparemela.com

Latest Breaking News On - News ratings for fusion pharmaceuticals daily - Page 4 : comparemela.com

FY2023 Earnings Forecast for Fusion Pharmaceuticals Inc. Issued By Bloom Burton (NASDAQ:FUSN)

FY2023 Earnings Forecast for Fusion Pharmaceuticals Inc. Issued By Bloom Burton (NASDAQ:FUSN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Wellington
New-zealand-general
New-zealand
Leerink-partnrs
Chartwell-investment-partners
Wellington-management-group
News-ratings-for-fusion-pharmaceuticals-daily
Royal-bank
Goldman-sachs-group-inc
Fusion-pharmaceuticals-inc

Royal Bank of Canada Reiterates "Sector Perform" Rating for Fusion Pharmaceuticals (NASDAQ:FUSN)

Royal Bank of Canada Reiterates "Sector Perform" Rating for Fusion Pharmaceuticals (NASDAQ:FUSN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Canada
Leerink-partnrs
News-ratings-for-fusion-pharmaceuticals-daily
Fusion-pharmaceuticals-inc
Renaissance-technologies
Jefferies-financial-group
York-state-common-retirement-fund
Institutional-trading-of-fusion-pharmaceuticals
Royal-bank
Fusion-pharmaceuticals-stock-performance

Fusion Pharmaceuticals (NASDAQ:FUSN) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. Several other research firms also recently weighed in on FUSN. Royal Bank of Canada reiterated a sector perform rating and issued a $21.00 target price (up previously from $16.00) […]

Canada
Wellington
New-zealand-general
New-zealand
United-states
Raymond-james
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-company-profile
Jefferies-financial-group
News-ratings-for-fusion-pharmaceuticals-daily
Hermes-inc
Sphera-funds-management

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
William-blair
Fusion-pharmaceuticals-profile
Exchange-commission
Citadel-advisors
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Schonfeld-strategic-advisors
Renaissance-technologies
Jefferies-financial-group

Fusion Pharmaceuticals (NASDAQ:FUSN) Downgraded by B. Riley

Fusion Pharmaceuticals (NASDAQ:FUSN) Downgraded by B. Riley
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Raymond-james
Leerink-partnrs
Fusion-pharmaceuticals-company-profile
Fusion-pharmaceuticals-inc
Analyst-recommendations-for-fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Hermes-inc
Fusion-pharmaceuticals
Perceptive-advisors
Fusion-pharmaceuticals-trading
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.